Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Calvert

Showing results (191-200 of 204) with videos related to

Pageof 21
Sort By:
Occupational and Environmental Medicine|October 30, 2012
The Upper Midwest Health Study: gliomas and occupational exposure to chlorinated solventsAvima M Ruder, James H Yiin, Martha A Waters, et al.
Emerging Infectious Diseases|April 4, 2012
Influenza-associated hospitalizations by industry, 2009-10 influenza season, United StatesSara E Luckhaupt, Marie Haring Sweeney, Renee Funk, et al.
Environmental Health Perspectives|May 4, 2005
Gliomas and farm pesticide exposure in women: the Upper Midwest Health StudyTania Carreón, Mary Ann Butler, Avima M Ruder, et al.
Archives of Environmental Health|June 23, 2006
Gliomas and farm pesticide exposure in men: the upper midwest health studyAvima M Ruder, Martha A Waters, Mary Ann Butler, et al.
Journal of Agricultural Safety and Health|November 30, 2006
The Upper Midwest Health Study: a case-control study of primary intracranial gliomas in farm and rural residentsA M Ruder, M A Waters, T Carreón, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2004
Reproductive factors and risk of glioma in womenKui Huang, Elizabeth A Whelan, Avima M Ruder, et al.
Gynecologic Oncology|September 15, 2019
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancerI Vergote, A du Bois, A Floquet, et al.
Cancer|April 15, 2023
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trialMansoor R Mirza, Antonio González-Martín, Whitney S Graybill, et al.
The Science of the Total Environment|November 19, 2023
Inter-colony variation in predation, mercury burden and adult survival in a declining seabirdAnna M Calvert, Sarah E Gutowsky, David A Fifield, et al.
Gynecologic Oncology|May 13, 2022
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 studyRoisin E O'Cearbhaill, Jose-Alejandro Pérez-Fidalgo, Bradley J Monk, et al.
Pageof 21

Showing results (191-200 of 204) with videos related to

Sort By:
Pageof 21
Occupational and Environmental Medicine|October 30, 2012
The Upper Midwest Health Study: gliomas and occupational exposure to chlorinated solventsAvima M Ruder, James H Yiin, Martha A Waters, et al.
Emerging Infectious Diseases|April 4, 2012
Influenza-associated hospitalizations by industry, 2009-10 influenza season, United StatesSara E Luckhaupt, Marie Haring Sweeney, Renee Funk, et al.
Environmental Health Perspectives|May 4, 2005
Gliomas and farm pesticide exposure in women: the Upper Midwest Health StudyTania Carreón, Mary Ann Butler, Avima M Ruder, et al.
Archives of Environmental Health|June 23, 2006
Gliomas and farm pesticide exposure in men: the upper midwest health studyAvima M Ruder, Martha A Waters, Mary Ann Butler, et al.
Journal of Agricultural Safety and Health|November 30, 2006
The Upper Midwest Health Study: a case-control study of primary intracranial gliomas in farm and rural residentsA M Ruder, M A Waters, T Carreón, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2004
Reproductive factors and risk of glioma in womenKui Huang, Elizabeth A Whelan, Avima M Ruder, et al.
Gynecologic Oncology|September 15, 2019
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancerI Vergote, A du Bois, A Floquet, et al.
Cancer|April 15, 2023
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trialMansoor R Mirza, Antonio González-Martín, Whitney S Graybill, et al.
The Science of the Total Environment|November 19, 2023
Inter-colony variation in predation, mercury burden and adult survival in a declining seabirdAnna M Calvert, Sarah E Gutowsky, David A Fifield, et al.
Gynecologic Oncology|May 13, 2022
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 studyRoisin E O'Cearbhaill, Jose-Alejandro Pérez-Fidalgo, Bradley J Monk, et al.
Pageof 21